Granules India Ltd

NSE:GRANULES (India)  
₹ 424.05 (+1.46%) Apr 26
26.03
P/B:
3.47
Market Cap:
₹ 102.84B ($ 1.23B)
Enterprise V:
₹ 113.49B ($ 1.36B)
Volume:
1.03M
Avg Vol (2M):
882.71K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Granules India Ltd ( ) from 2005 to Apr 29 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Granules India stock (NSE:GRANULES) PE ratio as of Apr 29 2024 is 26.03. More Details

Granules India Ltd (NSE:GRANULES) PE Ratio (TTM) Chart

To

Granules India Ltd (NSE:GRANULES) PE Ratio (TTM) Historical Data

Total 1265
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
Granules India PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-04-29 26.0 2024-02-26 28.8
2024-04-26 26.0 2024-02-23 28.6
2024-04-25 25.6 2024-02-22 28.2
2024-04-24 25.6 2024-02-21 28.1
2024-04-23 25.4 2024-02-20 28.4
2024-04-22 25.4 2024-02-19 28.5
2024-04-19 25.2 2024-02-16 28.0
2024-04-18 25.4 2024-02-15 26.8
2024-04-17 25.5 2024-02-14 26.5
2024-04-16 25.5 2024-02-13 26.4
2024-04-15 25.1 2024-02-12 25.9
2024-04-12 25.9 2024-02-09 25.7
2024-04-11 26.2 2024-02-08 26.2
2024-04-10 26.2 2024-02-07 26.7
2024-04-09 26.1 2024-02-06 26.3
2024-04-08 26.9 2024-02-05 26.2
2024-04-05 27.8 2024-02-02 25.8
2024-04-04 27.3 2024-02-01 25.3
2024-04-03 27.8 2024-01-31 25.5
2024-04-02 27.3 2024-01-30 25.1
2024-04-01 26.9 2024-01-29 25.2
2024-03-29 26.4 2024-01-26 25.4
2024-03-28 26.4 2024-01-25 25.4
2024-03-27 26.4 2024-01-24 25.6
2024-03-26 26.6 2024-01-23 25.3
2024-03-25 26.4 2024-01-22 25.9
2024-03-22 26.4 2024-01-19 25.9
2024-03-21 26.2 2024-01-18 25.9
2024-03-20 25.4 2024-01-17 25.8
2024-03-19 25.4 2024-01-16 26.3
2024-03-18 25.7 2024-01-15 26.4
2024-03-15 25.7 2024-01-12 25.1
2024-03-14 25.9 2024-01-11 25.2
2024-03-13 25.3 2024-01-10 24.8
2024-03-12 26.3 2024-01-09 25.1
2024-03-11 27.0 2024-01-08 24.6
2024-03-08 28.1 2024-01-05 25.4
2024-03-07 28.1 2024-01-04 25.6
2024-03-06 28.1 2024-01-03 25.8
2024-03-05 28.7 2024-01-02 25.8
2024-03-04 28.6 2024-01-01 25.3
2024-03-01 28.4 2023-12-29 24.9
2024-02-29 28.5 2023-12-28 24.2
2024-02-28 28.2 2023-12-27 24.5
2024-02-27 28.7 2023-12-26 24.4

Granules India Ltd (NSE:GRANULES) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Granules India Ltd is an India-based pharmaceutical company. The company manufactures active pharmaceutical ingredients, pharmaceutical formulation intermediates and finished dosages. Its business is organized into three areas; the Core business which comprises core molecules such as Paracetamol, Ibuprofen, Metformin, Guaifenesin, and Methocarbamol; the Emerging business that focuses on manufacturing APIs and the US Generics. It has one segment Pharmaceutical products including ingredients and intermediaries. Its primary geographic markets are North America, Latin America, Europe, India, and Rest of World.